Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Mazdutide is a dual GLP-1 / glucagon receptor agonist licensed from Eli Lilly to Innovent Biologics for Greater China. Approved by China's NMPA in June 2025 for chronic weight management and in September 2025 for glycemic control in type 2 diabetes; NOT FDA-approved in the US.
Lowest Price
$74.25
Highest Price
$810.00
Average Price
$229.87
Potential Savings
86%
across 6 options
0 of 6 vendors are lab-verified for Mazdutide
We cross-check each vendor's Certificate of Analysis against the issuing lab's own verification portal — so “cheapest” isn't the only signal.
Best price trend
Lowest $/mg for Mazdutide · last 33 days
$2.70/mg
▼ 79% vs 33d ago
Trust grade first, cheapest within grade
vial · 60mghydroresearchpeptides.com· price updated today
Lot 2024-08-05· tested 2024-08-28
$13.50/mg
80% more per mg
vial · 50mgzztai-tech.com· price updated today
$2.70/mg
vial · 10mgsouthernaminos.com· price updated today
$99.00−25%
$74.25$7.42/mg
64% more per mg
vial · 10mgwellilabs.com· price updated today
$8.00/mg
66% more per mg
vial · 6mgamc-essentials.com· price updated today
$15.00/mg
82% more per mg
vial · 10mggeneticpeptide.com· price updated today
$275.00−31%
$190.00$19.00/mg
86% more per mg
vial · 10mgcertified-pep.com· price updated today
$12.80/mg
79% more per mg
vial · 6mgsolutionpeptides.net· price updated today
$13.33/mg
80% more per mg
vial · 6mgpolarispeptides.com· price updated yesterday
$110.00−9%
$100.00$16.67/mg
84% more per mg
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Every vendor on this page is verified for endotoxin testing — not just HPLC purity.
Phase 3 GLORY-1 (Ji et al., NEJM 2025) in 610 Chinese adults with obesity/overweight reported mean weight loss of ~11.0% (4 mg) and ~14.0% (6 mg) vs +0.3% placebo at 48 weeks. Additional Phase 3 programs (GLORY-2 obesity, DREAMS-1/2/3 T2DM) supported the NMPA approvals; a 9 mg supplementary application for moderate-to-severe obesity is under NMPA review.
This platform provides informational tools only, not medical advice.
Prices verified as of June 2026. Actual prices may vary. For research use only.
Prices are estimates and may vary. For research use only. We may earn a commission on purchases through affiliate links. Not medical advice.
2025